Navellier & Associates Inc. Makes New Investment in Phibro Animal Health Corporation (NASDAQ:PAHC)

Key Points

• Navellier & Associates Inc. acquired a new stake in Phibro Animal Health Corporation, purchasing 44,943 shares valued at approximately $878,000.
• The stock of Phibro Animal Health recently reported a 0.63 earnings per share (EPS), exceeding the consensus estimate by $0.11, despite revenues falling short of analyst expectations.
• Several analysts have set new price targets for Phibro Animal Health, with JPMorgan Chase raising their target from $25.00 to $35.00, after upgrading the stock from "neutral" to "overweight."

Navellier & Associates Inc. bought a new stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 44,943 shares of the company's stock, valued at approximately $878,000. Navellier & Associates Inc. owned 0.11% of Phibro Animal Health as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Axecap Investments LLC acquired a new stake in shares of Phibro Animal Health during the first quarter worth about $3,696,000. Millennium Management LLC increased its stake in shares of Phibro Animal Health by 233.0% during the 4th quarter. Millennium Management LLC now owns 207,749 shares of the company's stock worth $4,363,000 after purchasing an additional 145,359 shares in the last quarter. Jacobs Levy Equity Management Inc. grew its stake in Phibro Animal Health by 56.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock worth $6,325,000 after acquiring an additional 108,918 shares during the period. Nuveen Asset Management LLC grew its stake in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after acquiring an additional 103,618 shares during the period. Finally, Alliancebernstein L.P. grew its stake in Phibro Animal Health by 357.1% in the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock worth $2,730,000 after acquiring an additional 101,560 shares during the period. Institutional investors and hedge funds own 99.34% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a report on Wednesday, June 25th. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $25.00 to $35.00 in a report on Monday, July 7th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, BNP Paribas Exane upgraded shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective on the stock in a report on Monday, June 16th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $24.40.

Phibro Animal Health Stock Up 1.0%

PAHC stock traded up $0.28 during trading on Wednesday, reaching $28.29. The stock had a trading volume of 28,203 shares, compared to its average volume of 258,652. The firm has a fifty day moving average price of $26.48 and a 200 day moving average price of $23.17. The company has a market capitalization of $1.15 billion, a P/E ratio of 36.27, a PEG ratio of 0.48 and a beta of 0.75. Phibro Animal Health Corporation has a 1-year low of $16.16 and a 1-year high of $31.80. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.11. The company had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. On average, equities analysts anticipate that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.70%. Phibro Animal Health's payout ratio is currently 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.